Eli Lilly to codevelop Covid19 therapies with AbCellera

Eli Lilly to co-develop Covid-19 therapies with AbCellera

07:35 EDT 13 Mar 2020 | Pharmaceutical Technology

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Follow the latest updates of the outbreakĀ on ourĀ timeline....
Read More...

The post Eli Lilly to co-develop Covid-19 therapies with AbCellera appeared first on Pharmaceutical Technology.

Original Article: Eli Lilly to co-develop Covid-19 therapies with AbCellera

More From BioPortfolio on "Eli Lilly to co-develop Covid-19 therapies with AbCellera"